WR-2,721: Enhanced chemoprotection by increasing cyclophosphamide activation with phenobarbitol
- 30 April 1982
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (3-4) , 571-574
- https://doi.org/10.1016/0360-3016(82)90686-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A more general role for WR-2721 in cancer therapyBritish Journal of Cancer, 1980
- Distribution and pharmacokinetics of cyclophosphamide in the ratBritish Journal of Cancer, 1980
- Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.British Journal of Clinical Pharmacology, 1979
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1979
- Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouseBritish Journal of Cancer, 1978
- The Metabolic Fate of CyclophosphamideDrug Metabolism Reviews, 1975
- The Biotransformation of Cyclophosphamide in Man: Analysis of the Variation in Normal SubjectsActa Pharmacologica et Toxicologica, 1974
- Antineoplastic and Immunosuppressive Drugs1 IDrugs, 1972
- METABOLISM OF ANTICANCER AGENTS IN MANAnnals of the New York Academy of Sciences, 1971